Mechanisms of allergen-specific immunotherapy.
暂无分享,去创建一个
[1] C. Akdis,et al. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. , 2002, The Journal of allergy and clinical immunology.
[2] R. Aalberse,et al. IgG4 breaking the rules , 2002, Immunology.
[3] Min Zhang,et al. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. , 2002, Nature medicine.
[4] C. Akdis,et al. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. , 2001, Microbes and infection.
[5] A. Sewell,et al. Bypassing IgE and targeting T cells for specific immunotherapy of allergy , 2001 .
[6] I. Bellinghausen,et al. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells. , 1999, The Journal of allergy and clinical immunology.
[7] G. Canonica,et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis , 1998, The Lancet.
[8] W. Dolen,et al. Use of thiocyanate elution to estimate relative avidity of allergen specific IgE antibodies. , 1997, Allergy and asthma proceedings.
[9] P. Venge,et al. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. , 1997, The Journal of allergy and clinical immunology.
[10] R. Ree,et al. Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] M. Jutel,et al. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[12] C. Akdis,et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. , 1996, The Journal of clinical investigation.
[13] M. Jordana,et al. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. , 1996, The Journal of clinical investigation.
[14] B. Eberlein-König,et al. Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization * , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[15] M. Goldman,et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. , 1994, Journal of immunology.
[16] P. Venge,et al. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. , 1990, The Journal of allergy and clinical immunology.
[17] N. Yamaguchi,et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production , 1989, The Journal of experimental medicine.
[18] A. Helbling,et al. Predictive value of venom‐specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom , 1989, Allergy.
[19] J. Bousquet,et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. , 1988, The Journal of allergy and clinical immunology.
[20] P. Venge,et al. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. , 1988, The Journal of allergy and clinical immunology.
[21] R. Naclerio,et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. , 1985, The Journal of clinical investigation.
[22] G. Gleich,et al. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. , 1982, The Journal of allergy and clinical immunology.
[23] D. Meyers,et al. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. , 1982, Journal of Allergy and Clinical Immunology.